DD

Dattatray Dhanaji Gaikwad

Active Director Additional Director DIN 10466981
DIN 10466981 First appointment Jan 2024 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dattatray Dhanaji Gaikwad

Data last updated:

Dattatray Dhanaji Gaikwad is an Additional Director at Aurus Pharma Private Limited (since 2024). The company operates in Wood.

DIN 10466981
Primary Designation Additional Director
Industry Wood
First Appointment 16 Jan 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aurus Pharma Private Limited U20116PN2023PTC224075
Additional Director16 Jan 20242023Active

Board colleagues of Dattatray Dhanaji Gaikwad

NameDINCompanyDesignation
Rajeshri Vijay Jagdale10321753Aurus Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aurus Pharma Private Limited
Premium access

Shareholding and investment profile for Dattatray Dhanaji Gaikwad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dattatray Dhanaji Gaikwad

Dattatray Dhanaji Gaikwad currently holds 1 directorship: Aurus Pharma Private Limited (Additional Director, since 16 Jan 2024).

Dattatray Dhanaji Gaikwad was first appointed on 16 Jan 2024 as Additional Director at Aurus Pharma Private Limited.

The current boards of Dattatray Dhanaji Gaikwad's companies include Rajeshri Vijay Jagdale (Aurus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available